Zdrowie i gospodarka · 20/12/2010
DARPA and FDA Expand Workshop on In Vivo Biomarker Detection Devices
DARPA and the FDA are expanding their workshop on in vivo biomarker detection devices, a technology that enables real-time monitoring of diseases in living organisms.
Source: Federal Register — Health and Human ServicesOpen original release →